HERmark Breast Cancer Assay
To educate and generate interest in HERmark®, a new HER2 assay for metastatic breast cancer, it was important to differentiate the product from previous assays, because it has the ability to assist oncologists in individualizing each patient’s treatment with more dimension and detail than ever before. Our team created a campaign featuring a unique illustration style that conveyed the HERmark difference: a more accurate, more detailed look at HER2 total protein expression and dimerization.
The launch sales aid, artwork, and collateral materials have received numerous industry creative awards, including IN-AWE Gold and Silver from the Healthcare Communication & Marketing Association and category wins from the Diagnostic Marketing Association. Our Teaching Tool/Calendar won a first place 2010 Dx Creative Communications Award!